Human Heredity and Health in Africa Steering Committee

Human Heredity and Health in Africa Steering Committee
Name	Human Heredity and Health in Africa Steering Committee
Abbreviation	H3Africa SC
Formation	2010s
Type	Research steering committee
Headquarters	Addis Ababa, Nairobi
Region served	Africa
Parent organization	National Institutes of Health / Wellcome Trust

Human Heredity and Health in Africa Steering Committee The Human Heredity and Health in Africa Steering Committee guided the pan-African research program that coordinated genomic, epidemiological, and bioinformatics projects across Nigeria, South Africa, Kenya, Ethiopia, Ghana, Senegal, Uganda, Tanzania and other countries. It linked funders such as the National Institutes of Health, the Wellcome Trust, and the African Academy of Sciences with research institutions including University of Cape Town, Makerere University, University of Ibadan, University of Nairobi, and the Council for Scientific and Industrial Research.

Background and Establishment

The Steering Committee emerged during meetings involving representatives from National Human Genome Research Institute, Wellcome Trust Sanger Institute, African Society of Human Genetics, African Academy of Sciences, African Union, and philanthropic partners like the Bill & Melinda Gates Foundation. Stakeholders from Harvard University, University of Oxford, University of Cambridge, Stanford University, Duke University School of Medicine, and African centers negotiated scope, governance, and funding. Founding convenings referenced precedents such as the International HapMap Project, the 1000 Genomes Project, and collaborations with Centers for Disease Control and Prevention and national ministries of health in Botswana and Rwanda.

Mission and Objectives

The committee set objectives aligning with continental priorities articulated by African Union Commission and pan-African initiatives like the African Union Development Agency. Core goals included improving understanding of human genetic variation relevant to diseases prevalent in Sub-Saharan Africa, informing clinical practice in contexts represented by Kenya Medical Research Institute, South African Medical Research Council, and integrating outputs into policy frameworks referenced by World Health Organization regional offices and the United Nations Economic Commission for Africa.

Governance and Membership

Membership combined leaders from academic institutions such as University of Lagos, Stellenbosch University, University of Ghana, and University of the Witwatersrand with funder representatives from Wellcome Trust, NIH, and program officers from Howard Hughes Medical Institute. Governance structures drew on models used by bodies like the European Molecular Biology Laboratory and the Global Alliance for Genomics and Health, establishing technical working groups linked to ethics committees at Makerere University School of Public Health and data access committees referencing the PLOS data-sharing policies. Notable affiliated investigators included scientists affiliated with Broad Institute, McGill University, University of California, Los Angeles, and Karolinska Institutet.

Major Initiatives and Activities

The committee coordinated multicenter projects that supported genome-wide association studies (GWAS) in cohorts recruited through hospitals such as Chris Hani Baragwanath Hospital and research networks including the African Network for Drugs and Diagnostics Innovation. Activities encompassed biobanking strategies inspired by UK Biobank, development of population reference panels paralleling the 1000 Genomes Project, and capacity in bioinformatics through training partnerships with Carnegie Mellon University and University of Pennsylvania. Collaborative studies addressed diseases prioritized by Médecins Sans Frontières and The Global Fund like sickle cell disease, malaria, hypertension, and diabetes, engaging laboratories accredited by South African National Accreditation System and clinical sites in Accra and Lagos.

Ethics, Community Engagement, and Capacity Building

Ethical frameworks referenced guidance from the World Health Organization, the Council for International Organizations of Medical Sciences, and national ethics bodies in Zambia and Mozambique. The committee promoted community engagement models based on precedents from Wellcome Trust–funded public engagement programs and partnerships with civil society organizations such as African Women in Science and Engineering. Capacity building included scholarships, fellowships, and infrastructure investments modeled after programs at Kwame Nkrumah University of Science and Technology and exchanges with Yale University and Johns Hopkins University.

Impact and Outcomes

Outcomes included expanded genomic datasets representing diverse African populations, improved laboratory networks at institutions like Ahmadu Bello University, and trained cohorts of researchers now affiliated with London School of Hygiene & Tropical Medicine, University College London, and African universities. Publications appeared in journals such as Nature, Science, Nature Genetics, and The Lancet, and findings informed clinical guidelines considered by ministries in Nigeria and South Africa as well as initiatives by African Centres for Disease Control and Prevention.

Challenges and Criticisms

Critiques addressed data sovereignty concerns raised by advocates connected to Open Society Foundations and debates about benefit-sharing involving representatives from African Studies Association and community advisory boards in Dar es Salaam. Operational challenges included disparities in research infrastructure between institutions like University of Pretoria and smaller regional hospitals, and tensions over authorship and intellectual property discussed at symposia hosted by Royal Society and American Society of Human Genetics.

Category:Genomics Category:Public health in Africa